Gain, but what, how much and at what cost?
Schrijvers
Dirk
D
Department of Medical Oncology, AZ Jan Palfijn, Merksem, Belgium. Electronic address: dirk.schrijvers@zna.be.
D003362:Cost-Benefit Analysis; D006801:Humans; D009369:Neoplasms / Q000191:economics* / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D011788:Quality of Life; D015996:Survival Rate